466 related articles for article (PubMed ID: 23975926)
1. Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase.
Jonigk D; Al-Omari M; Maegel L; Müller M; Izykowski N; Hong J; Hong K; Kim SH; Dorsch M; Mahadeva R; Laenger F; Kreipe H; Braun A; Shahaf G; Lewis EC; Welte T; Dinarello CA; Janciauskiene S
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):15007-12. PubMed ID: 23975926
[TBL] [Abstract][Full Text] [Related]
2. High-density lipoproteins potentiate α1-antitrypsin therapy in elastase-induced pulmonary emphysema.
Moreno JA; Ortega-Gomez A; Rubio-Navarro A; Louedec L; Ho-Tin-Noé B; Caligiuri G; Nicoletti A; Levoye A; Plantier L; Meilhac O
Am J Respir Cell Mol Biol; 2014 Oct; 51(4):536-49. PubMed ID: 24787644
[TBL] [Abstract][Full Text] [Related]
3. Strategies for aerosol therapy of alpha 1-antitrypsin deficiency by the aerosol route.
Hubbard RC; Crystal RG
Lung; 1990; 168 Suppl():565-78. PubMed ID: 2117165
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic benefits of recombinant alpha1-antitrypsin IgG1 Fc-fusion protein in experimental emphysema.
Takeda K; Kim SH; Joetham A; Petrache I; Gelfand EW
Respir Res; 2021 Jul; 22(1):207. PubMed ID: 34271910
[TBL] [Abstract][Full Text] [Related]
5. Historical role of alpha-1-antitrypsin deficiency in respiratory and hepatic complications.
Zuo L; Pannell BK; Zhou T; Chuang CC
Gene; 2016 Sep; 589(2):118-22. PubMed ID: 26768576
[TBL] [Abstract][Full Text] [Related]
6. Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency.
Hubbard RC; McElvaney NG; Sellers SE; Healy JT; Czerski DB; Crystal RG
J Clin Invest; 1989 Oct; 84(4):1349-54. PubMed ID: 2794066
[TBL] [Abstract][Full Text] [Related]
7. α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8.
Bergin DA; Reeves EP; Meleady P; Henry M; McElvaney OJ; Carroll TP; Condron C; Chotirmall SH; Clynes M; O'Neill SJ; McElvaney NG
J Clin Invest; 2010 Dec; 120(12):4236-50. PubMed ID: 21060150
[TBL] [Abstract][Full Text] [Related]
8. Autoprocessing of neutrophil elastase near its active site reduces the efficiency of natural and synthetic elastase inhibitors.
Dau T; Sarker RS; Yildirim AO; Eickelberg O; Jenne DE
Nat Commun; 2015 Apr; 6():6722. PubMed ID: 25857284
[TBL] [Abstract][Full Text] [Related]
9. Alpha-1 antitrypsin: now available, but do we need it?
Russi EW
Swiss Med Wkly; 2008 Apr; 138(13-14):191-6. PubMed ID: 18389391
[TBL] [Abstract][Full Text] [Related]
10. Sex-specific differences in emphysema using a murine antisense oligonucleotide model of α-1 antitrypsin deficiency.
Joshi R; Ojha M; Lewis J; Fan Q; Monia B; Guo S; Varisco BM
Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L1165-L1173. PubMed ID: 31017014
[TBL] [Abstract][Full Text] [Related]
11. Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individuals.
Hurley K; Lacey N; O'Dwyer CA; Bergin DA; McElvaney OJ; O'Brien ME; McElvaney OF; Reeves EP; McElvaney NG
J Immunol; 2014 Oct; 193(8):3978-91. PubMed ID: 25217166
[TBL] [Abstract][Full Text] [Related]
12. The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.
O'Dwyer CA; O'Brien ME; Wormald MR; White MM; Banville N; Hurley K; McCarthy C; McElvaney NG; Reeves EP
J Immunol; 2015 Oct; 195(8):3628-41. PubMed ID: 26371243
[TBL] [Abstract][Full Text] [Related]
13. The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency.
Schmid ST; Koepke J; Dresel M; Hattesohl A; Frenzel E; Perez J; Lomas DA; Miranda E; Greulich T; Noeske S; Wencker M; Teschler H; Vogelmeier C; Janciauskiene S; Koczulla AR
Int J Chron Obstruct Pulmon Dis; 2012; 7():687-96. PubMed ID: 23055718
[TBL] [Abstract][Full Text] [Related]
14. Alpha 1 Antitrypsin-Deficient Macrophages Have Impaired Efferocytosis of Apoptotic Neutrophils.
Lee J; Lu Y; Oshins R; West J; Moneypenny CG; Han K; Brantly ML
Front Immunol; 2020; 11():574410. PubMed ID: 33329539
[TBL] [Abstract][Full Text] [Related]
15. Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release.
Nita I; Hollander C; Westin U; Janciauskiene SM
Respir Res; 2005 Jan; 6(1):12. PubMed ID: 15683545
[TBL] [Abstract][Full Text] [Related]
16. Preservation with α
Götzfried J; Smirnova NF; Morrone C; Korkmaz B; Yildirim AÖ; Eickelberg O; Jenne DE
J Heart Lung Transplant; 2018 Aug; 37(8):1021-1028. PubMed ID: 29776812
[TBL] [Abstract][Full Text] [Related]
17. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.
McCarthy C; Reeves EP; McElvaney NG
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S297-304. PubMed ID: 27564664
[TBL] [Abstract][Full Text] [Related]
18. Commercial α1-antitrypsin preparations markedly differ in their potential to inhibit the ATP-induced release of monocytic interleukin-1β.
Agné A; Richter K; Padberg W; Janciauskiene S; Grau V
Pulm Pharmacol Ther; 2021 Jun; 68():102020. PubMed ID: 33774155
[TBL] [Abstract][Full Text] [Related]
19. Understanding Lung Deposition of Alpha-1 Antitrypsin in Acute Experimental Mouse Lung Injury Model Using Fluorescence Microscopy.
Wang M; Zhan Y; Chen J; Rong H; O'Neil SP; Ghosh B; Nguyen V; Owens J; Li X; O'Hara DM
Int J Mol Imaging; 2016; 2016():5768312. PubMed ID: 28050284
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil recruitment into the lungs is associated with increased lung elastase burden, decreased lung elastin, and emphysema in alpha 1 proteinase inhibitor-deficient mice.
Cavarra E; Martorana PA; Gambelli F; de Santi M; van Even P; Lungarella G
Lab Invest; 1996 Aug; 75(2):273-80. PubMed ID: 8765327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
